Zambia Medicines Regulatory Authority - ZAMRA

Call Directions Website Contact the organization

Zambia Medicines Regulatory Authority - ZAMRA "Regulating Medicines for Public and Animal Health Protection"

Welcome Zambia Medicines Regulatory Authority (ZAMRA) formally known as the Pharmaceutical Regulatory Authority. ZAMRA is a Statutory National Medicines Regulatory Body for Zambia established under an Act of Parliament, the Medicines and Allied Substances Act No. 3 of 2013 of the Laws of Zambia to regulate and control the manufacture, importation, storage distribution, supply, sale and use of medicines and allied substances in Zambia.

Kindly make date!
06/10/2026

Kindly make date!

STRENGTHENING VACCINE SAFTEY SURVEILLANCE  ACROSS AFRICA.Southern Sun Hotel, Lusaka – 29th September 2026.The Zambia Med...
05/10/2026

STRENGTHENING VACCINE SAFTEY SURVEILLANCE ACROSS AFRICA.
Southern Sun Hotel, Lusaka – 29th September 2026.

The Zambia Medicines Regulatory Authority (ZAMRA) proudly joined partners from across the continent at the African Vaccine Safety Sentinel Surveillance Network (AVASSN) Launch and Training of Trainers Programme, hosted in Lusaka by Africa CDC from 28th September - 2nd November,2026.

The event brought together representatives from national regulatory authorities, public health institutions, and technical experts to advance Africa’s capacity for Adverse Events of Special Interest (AESI) surveillance.

In his opening remarks, the ZAMRA Director General Mr. Makomani Siyanga speaking through Director Licensing Surveillance and Inspection Mr. Mathews Mwale emphasized:

“Strong and reliable surveillance systems are essential to rapidly identify and respond to adverse events, and to generate evidence that supports public health and regulatory decisions.”

The gathering provided a platform for networking, knowledge exchange, and collaboration, reinforcing Africa’s collective commitment to safeguarding communities and maintaining confidence in immunization programmes.







30/09/2026

Session Highlights: Southern Africa Regulatory Updates Zambia and Zimbabwe shared updates on their national regulatory systems, current priorities and the progress taking shape within their respective markets. Moderated by: Dr. Myles G., National CPD Co-ordinator, The Pharmaceutical Society of Kenya...

ZAMRA BUILDS CAPACITY FOR HUMAN MEDICINES ASSESSORS IN BIOEQUIVALENCE EVALUATIONThe Zambia Medicines Regulatory Authorit...
29/09/2026

ZAMRA BUILDS CAPACITY FOR HUMAN MEDICINES ASSESSORS IN BIOEQUIVALENCE EVALUATION

The Zambia Medicines Regulatory Authority (ZAMRA) is conducting a five-day training for Human Medicines Assessors aimed at strengthening their capacity in the evaluation of bioequivalence (BE) studies and related clinical evidence for generic medicines.

The training, which started on 28th September and running up to 2nd October 2026 at Cresta Golfview Hotel, forms part of ZAMRA’s continued efforts to build technical capacity in medicines regulation.

Bioequivalence assessment helps establish that a generic medicine delivers the active ingredient into the body at a comparable rate and extent to the reference product, providing the scientific basis for expecting comparable therapeutic performance.

Giving the opening remarks, Principal Registration Officer – Human Medicines, Mr. Sakeni Hadebe, emphasised the importance of equipping assessors with the skills required for robust and scientifically sound BE assessments.

Senior Registration Officer, Mrs. Constance Chisha, presented on the Principles of Interchangeability and encouraged participants to explore opportunities in clinical trials, noting Africa’s historically limited participation in clinical research despite its significant disease burden.

Other facilitators include Mr. Matthews Mweetwa, Ms. Miyanda Shakalima, Ms. Kalale Munenu, Mrs Mufaweli Mwale and Ms. Mary Nonde.

The training is expected to enhance consistency and scientific rigour in the assessment of generic medicines dossiers, contributing to stronger medicines regulatory systems and protection of public health.





ZAMBIA HOSTS REGIONAL MEDICINES REGULATORY TRAINING AND PEER LEARNING WORKSHOP The Zambia Medicines Regulatory Authority...
28/09/2026

ZAMBIA HOSTS REGIONAL MEDICINES REGULATORY TRAINING AND PEER LEARNING WORKSHOP

The Zambia Medicines Regulatory Authority (ZAMRA) Director-General, Mr. Makomani Siyanga, has called for stronger regional collaboration among medicines regulatory authorities to strengthen medicines regulation across Africa.

Mr. Siyanga said no single National Medicines Regulatory Authority (NMRA) can address the full scope of modern medicines regulation alone, adding that the region is stronger when regulators train together, inspect together and learn from one another’s experiences.

He was speaking when he officially opened the Regional Training and Peer Learning Workshop organised by the Common Market for Eastern and Southern Africa (COMESA), with support from the African Development Fund.

This was in a speech delivered on his behalf by Director - Licensing, Surveillance and Enforcement, Mr. Matthews Mwale.

The workshop, taking place from 28th to 30th September 2026 at Ciela Resort in Chongwe, is part of the implementation of the regional NMRA Capacity-Building Programme under the COMESA Support Towards Regional Pharmaceutical Sector Development (CSTRPSD).

The programme follows an assessment of NMRAs across the region, which recommended the establishment of Communities of Practice (CoPs) for medicines assessors, Good Manufacturing Practice (GMP) inspectors, pharmacovigilance (PV) officers and post-marketing surveillance (PMS) personnel.

Meanwhile, COMESA Acting Director - Industry and Agriculture Division, Ms. Esther Mwimba, said the initiative will focus on establishing functional Communities of Practice, implementable training and certification pathways, and a clear roadmap to help NMRAs identify their current capacity and areas for advancement.

The workshop provides a platform to validate the regional needs assessment, share knowledge and experiences, and advance regulatory convergence towards stronger medicines regulatory systems across COMESA.

These efforts contribute towards a harmonised and mutually trusted African regulatory architecture, anchored in the work of the African Medicines Agency (AMA) and the African Union Model Law on Medical Products Regulation.






28/09/2026

📢 Employment Opportunities at ZAMRA

The Zambia Medicines Regulatory Authority (ZAMRA) is inviting applications from suitably qualified and ambitious Zambian citizens to join our team in various positions across regulatory, communications, legal, human resource, laboratory, and inspection functions.

Interested candidates are encouraged to review the full job advertisement and application details via the link below:

👉https://www.zamra.co.zm/wp-content/uploads/2026/09/ZAMRA_Job_Advertisement-_Friday_25_September_2026_Final_Copy_Revised.pdf

Deadline for applications: 2nd October 2026

ZAMRA is an equal opportunity employer.

ZAMRA SENSITISES STUDENTS FROM THE SCHOOL OF MEDICINE AND HEALTH SCIENCES ON MEDICINE SAFETY AT UNILUSThe Zambia Medicin...
26/09/2026

ZAMRA SENSITISES STUDENTS FROM THE SCHOOL OF MEDICINE AND HEALTH SCIENCES ON MEDICINE SAFETY AT UNILUS

The Zambia Medicines Regulatory Authority (ZAMRA) Pharmacovigilance Unit has continued its sensitisation activities in higher learning institutions, aimed at equipping future health professionals with knowledge on ZAMRA’s mandate and the importance of medicine safety monitoring.

Yesterday, the team visited the University of Lusaka, where it engaged students in the Faculty of Medicine and Health Sciences on the importance of pharmacovigilance and responsible use of medicines.

Early training of medical students on medicine safety is essential in cultivating a strong culture of responsible practice from the beginning of their professional journey.

As future healthcare providers, students have an important role to play in protecting patients by promoting the safe and appropriate use of medicines, preventing and identifying medication errors, recognising adverse medicine reactions and reporting suspected adverse drug reactions.

By engaging students early, ZAMRA is helping to build a generation of health professionals who understand that medicine safety is a shared responsibility and an integral part of quality healthcare.





25/09/2026
ZAMRA, IBA LEAD STAKEHOLDER DIALOGUE ON MISLEADING HEALTH CLAIMS AND UNAPPROVED MEDICAL PRODUCTS The Zambia Medicines Re...
24/09/2026

ZAMRA, IBA LEAD STAKEHOLDER DIALOGUE ON MISLEADING HEALTH CLAIMS AND UNAPPROVED MEDICAL PRODUCTS

The Zambia Medicines Regulatory Authority (ZAMRA) has called for greater consideration of how traditional knowledge and practices can be developed into properly formulated, scientifically evaluated and evidence-based medicines that can be submitted for registration.

ZAMRA Director-General Mr Makomani Siyanga said this could provide greater assurance of quality, safety and efficacy, while protecting public health and creating opportunities for wider markets.

He was speaking today at a multi-stakeholder meeting jointly hosted by ZAMRA and the Independent Broadcasting Authority (IBA) at the Mulungushi International Conference Centre to address the airing of advertisements for unapproved medical products and misleading spiritual and health claims on radio and television.

Mr Siyanga noted that while ZAMRA does not have a legal mandate to regulate traditional beliefs or traditional medicine practices, the Authority is concerned where these involve the promotion of medical products, particularly unapproved products, or health claims that may mislead the public or expose vulnerable people to harm.

IBA Director-General Mr Webster Malido expressed concern over questionable spiritual and traditional content, as well as advertisements and promotional material for medical products and services. He stressed that broadcasting content should be presented accurately, fairly and responsibly.

Meanwhile, Zambia Institute of Marketing (ZIM) Vice Chairperson – Advertising Standards Board, Mr Billy Wamundila, stressed the need for compliance with applicable laws and regulations, while Evangelical Fellowship of Zambia (EFZ) Executive Director Rev. Allan Kasungami noted that faith and accountability are not mutually exclusive and that laws can be crafted to protect citizens from exploitation as the church flourishes.

Other speakers included representatives from the Zambia Conference of Catholic Bishops (ZCCB), Christian Council of Zambia, Media Owners Association of Zambia and Traditional Healers Association of Zambia (THAPAZ).

ZAMRA HOSTS IGAD TEAM AHEAD OF JOINT GMP INSPECTIONSA team of inspectors led by Dr Karim Wanga, Pharmaceutical Expert at...
22/09/2026

ZAMRA HOSTS IGAD TEAM AHEAD OF JOINT GMP INSPECTIONS

A team of inspectors led by Dr Karim Wanga, Pharmaceutical Expert at the Intergovernmental Authority on Development (IGAD), has paid a courtesy call on ZAMRA Director-General, Mr Makomani Siyanga, ahead of the Joint Coached and Supportive Good Manufacturing Practice (cGMP) Inspections scheduled for 21–25th September 2026.

The inspections will be conducted at Yashi Life Sciences Limited and NRB Pharma (Z) Limited under the Health Emergency Preparedness, Response and Resilience Multi-Phase Programme (HEPRR-MPA), implemented by IGAD in collaboration with the Eastern, Central and Southern Africa Health Community (ECSA-HC), with support from the World Bank.

The joint supportive audits are intended to assess compliance with international standards, identify gaps, support the development of Corrective and Preventive Actions (CAPAs) and provide technical assistance to address identified deficiencies.

The exercise will also assess the skills and competencies of GMP inspectors and inform targeted training programmes to strengthen inspection capacity.

Welcoming the team, Mr Siyanga described the exercise as an important opportunity to strengthen regulatory standards, facilities and human capital, contributing to the availability of quality-assured medicines and allied substances.

Dr Wanga emphasised the importance of raising manufacturing standards to international levels to ensure that medicines are safe, effective and trusted both within countries and across borders.

Meanwhile, Consultant Dr Washington Dengu said the exercise would also help develop the next generation of inspectors and strengthen manufacturers’ confidence in national and regional regulatory inspections.

The programme seeks to strengthen access to quality-assured, safe and effective medical products, while building capacity for local pharmaceutical and vaccine manufacturing in the Eastern and Southern Africa region.




Address

Plot #2350/M , P. O Box 31890 Off Airport Road, ZAF Bypass Route , Between Hitachi And Delta Auto
Lusaka
10101

Opening Hours

Monday 08:00 - 17:00
Tuesday 08:00 - 17:00
Wednesday 08:00 - 17:00
Thursday 08:00 - 17:00
Friday 08:00 - 17:00

Telephone

+260211432350

Alerts

Be the first to know and let us send you an email when Zambia Medicines Regulatory Authority - ZAMRA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Zambia Medicines Regulatory Authority - ZAMRA:

Shortcuts

Share

Nearby government services